Possible adverse effects of phenytoin given transplacentally on the fetal growth. I. Transplacental transmission of phenytoin.:I. Transplacental Transmission of Phenytoin
スポンサーリンク
概要
- 論文の詳細を見る
This study was undertaken to examine the transplacental transmission of phenytoin (PHT) and its possible adverse effects on the fetal growth. The animals used in this experiment were 8-week-old female mice of the ICR-JCL strain. When 50mg/kg of body weight of PHT was administered orally to mothers with chow, maternal serum levels of PHT were the lowest at noon and highest at midnight. The concentration of PHT in serum showed a close correlation with each dose increment, when blood was drown at a certain time. Serum levels of PHT in the fetus were about 80% of those in maternal serum on day 18 of gestation. The differences in serum levels of PHT between the fetuses and their mothers were attributed to the differences in levels of albumin-bound PHT, and the level of albumin- free PHT in the fetuses were almost same as that in their mothers.
- 一般社団法人 日本小児神経学会の論文
一般社団法人 日本小児神経学会 | 論文
- Levetiracetamが著効したSTXBP1遺伝子変異による大田原症候群の1例
- Cyclophosphamideが著効した抗NMDA受容体抗体脳炎の8歳男児例
- 重症心身障害医療からみた小児脳死に関する私見
- 幼児期発症の難治な多発性硬化症に対しcyclophosphamideパルス療法が有効であった1例
- Duchenne型筋ジストロフィー児への病気の説明に関する調査